CIK 0001430306
- Non-accelerated filer
- Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 261434750
- Phone
- +1 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- Open-market buys, last 90 days
- $47,855
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$47,855. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-12 | GRANGE DAVID L Director | Grant or award · Stock Option | +22,700 | 22,700 | ||
| 2025-05-13 | GRANGE DAVID L Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2024-05-23 | GRANGE DAVID L Director | Grant or award · Stock Option | +104,621 | 104,621 | ||
| 2023-05-08 | GRANGE DAVID L Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2022-05-09 | GRANGE DAVID L Director | Grant or award · Stock Option | +2,131,500 | 2,131,500 | ||
| 2021-05-10 | GRANGE DAVID L Director | Grant or award · Stock Option | +270,882 | 270,882 | ||
| 2020-05-04 | GRANGE DAVID L Director | Grant or award · Stock Option | +75,000 | 75,000 | ||
| 2019-05-06 | GRANGE DAVID L Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2018-06-12 | GRANGE DAVID L Director | Grant or award · Stock Option | +20,000 | 20,000 | ||
| 2018-02-13 | GRANGE DAVID L Director | Grant or award · Stock Option | +7,000 | 7,000 |
Page 1 of 1 · 10 trades